EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Extracellular Microvesicles vs. Mitochondria: Competing for the Top Spot in Cardiovascular Regenerative Medicine

David M Smadja iD

Stem Cell Reviews and Reports · 2024

DOI: 10.1007/s12015-024-10758-8 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Stem Cell Reviews and Reports, 2024. Verfasst von David M Smadja. Beteiligte Einrichtung: Université Paris Cité, INSERM, Innovative Therapies in Hemostasis, Paris, F-75006, France. david.smadja@me.com. Hauptthemen laut MEDLINE: Regenerative Medicine, Mitochondria, Extracellular Vesicles, Cardiovascular Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Regenerative medicine aims to restore, replace, and regenerate human cells, tissues, and organs. Despite significant advancements, many cell therapy trials for cardiovascular diseases face challenges like cell survival and immune compatibility, with benefits largely stemming from paracrine effects. Two promising therapeutic tools have been recently emerged in cardiovascular diseases: extracellular vesicles (EVs) and mitochondrial transfer. Concerning EVs, the first pivotal study with EV-enriched secretome derived from cardiovascular progenitor cells has been done treating heart failure. This first in man demonstrated the safety and feasibility of repeated intravenous infusions and highlighted significant clinical improvements, including enhanced cardiac function and reduced symptoms in heart failure patients. The second study uncovered a novel mechanism of endothelial regeneration through mitochondrial transfer via tunneling nanotubes (TNTs). This research showed that mesenchymal stromal cells (MSCs) transfer mitochondria to endothelial cells, significantly enhancing their bioenergetics and vessel-forming capabilities. This mitochondrial transfer was crucial for endothelial cell engraftment and function, offering a new strategy for vascular regeneration without the need for additional cell types. Combining EV and mitochondrial strategies presents new clinical opportunities. These approaches could revolutionize regenerative medicine, offering new hope for treating cardiovascular and other degenerative diseases. Continued research and clinical trials will be crucial in optimizing these therapies, potentially leading to personalized medicine approaches that enhance patient outcomes. Regenerative medicine seeks to restore, replace, and regenerate human cells, tissues, and organs, with recent advancements focusing on extracellular vesicles (EVs) and mitochondrial transfer for cardiovascular diseases. Pivotal studies have demonstrated that EV-enriched secretomes and mitochondrial transfer significantly improve cardiac function or endothelial regeneration, offering promising new strategies for cardiovascular diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Regenerative MedicineMitochondriaExtracellular VesiclesCardiovascular DiseasesHumansCell-Derived MicroparticlesMesenchymal Stem CellsAnimalsRegeneration

Stichwörter der Autor:innen

ECFCsExtracellular vesiclesHeart failureMitochondriaRegenerationStem cells

Autor:innen und Institutionen

  • Université Paris Cité, INSERM, Innovative Therapies in Hemostasis, Paris, F-75006, France. david.smadja@me.com.
  • Hematology Department, AP-HP, Georges Pompidou European Hospital, Inserm UMR-S1140, 56 rue Leblanc, Paris, F-75015, France. david.smadja@me.com.

ORCID-Profile: David M Smadja

Zitieren

APA

Smadja, D. M. (2024). Extracellular Microvesicles vs. Mitochondria: Competing for the Top Spot in Cardiovascular Regenerative Medicine. Stem Cell Reviews and Reports. https://doi.org/10.1007/s12015-024-10758-8

Vancouver

Smadja DM. Extracellular Microvesicles vs. Mitochondria: Competing for the Top Spot in Cardiovascular Regenerative Medicine. Stem Cell Reviews and Reports. 2024. doi:10.1007/s12015-024-10758-8

BibTeX
@article{Smadja2024,
  author = {Smadja, David M},
  title = {Extracellular Microvesicles vs. Mitochondria: Competing for the Top Spot in Cardiovascular Regenerative Medicine},
  journal = {Stem Cell Reviews and Reports},
  year = {2024},
  doi = {10.1007/s12015-024-10758-8}
}
Kostenlos starten →